Xiongxiong Liu
Overview
Explore the profile of Xiongxiong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi Z, Hu C, Liu J, Cheng W, Chen X, Liu X, et al.
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40003899
Increased stemness of cancer cells exacerbates radioresistance, thereby greatly limiting the efficacy of radiotherapy. In order to study the changes in cancer cell stemness during radiotherapy, we established a radioresistance...
2.
Liu X, Zheng T, Bao Y, Li P, Zhao T, Liu Y, et al.
Molecules
. 2025 Jan;
30(1.
PMID: 39795243
More than 70% of cancer patients receive radiotherapy during their treatment, with consequent various side effects on normal cells due to high ionizing radiation doses despite tumor shrinkage. To date,...
3.
He Q, Liu X, Xiao G, He X, Gong W, Tang L, et al.
Small
. 2024 Jul;
20(44):e2403660.
PMID: 39004850
All-solid-state lithium metal batteries (ASSLMBs) have emerged as the most promising next-generation energy storage devices. However, the unsatisfactory ionic conductivity of solid electrolytes at room temperature has impeded the advancement...
4.
Lin K, Wang Y, Liu F, You T, Liu X, Liu R, et al.
Eur J Med Res
. 2024 Mar;
29(1):206.
PMID: 38539263
Objective: It has been demonstrated that IDO1, a target of immune checkpoint inhibition, functions as an oncogene in the majority of human malignancies. IDO1's function in human pan-cancers hasn't been...
5.
Hu C, Shi Z, Liu X, Sun C
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38256247
Mitochondria are double-membrane organelles that are involved in energy production, apoptosis, and signaling in eukaryotic cells. Several studies conducted over the past decades have correlated mitochondrial dysfunction with various diseases,...
6.
Yu B, Lu X, Feng X, Zhao T, Li J, Lu Y, et al.
Int J Nanomedicine
. 2023 Dec;
18:7713-7728.
PMID: 38115988
Introduction: Radiotherapy is a widely recognized first-line clinical treatment for cancer, but its efficacy may be impeded by the radioresistance of advanced tumors. It is urgent to improve the sensitivity...
7.
Zheng X, Jin X, Ye F, Liu X, Yu B, Li Z, et al.
Exp Hematol Oncol
. 2023 Jul;
12(1):65.
PMID: 37501213
Background: Ferroptosis is a regulated cell death mode triggered by iron-dependent toxic membrane lipid peroxidation. As a novel cell death modality that is morphologically and mechanistically different from other forms...
8.
Liu X, Zhao T, Shi Z, Hu C, Li Q, Sun C
Molecules
. 2023 Jul;
28(13).
PMID: 37446609
Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects...
9.
Liu X, Sun C, Wang Q, Li P, Zhao T, Li Q
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445835
Radioresistance remains a critical obstacle in the clinical management of glioblastoma (GBM) by radiotherapy. Therefore, it is necessary to explore the molecular mechanisms underlying radioresistance to improve patient response to...
10.
Bao X, Liu X, Wu Q, Ye F, Shi Z, Xu D, et al.
Antioxidants (Basel)
. 2023 Feb;
12(2).
PMID: 36830013
Radiotherapy (RT) is one of the most effective cancer treatments. However, successful radiation protection for normal tissue is a clinical challenge. Our previous study observed that MitoQ, a mitochondria-targeted antioxidant,...